Loading
PDBj
メニューPDBj@FacebookPDBj@TwitterPDBj@YouTubewwPDB FoundationwwPDB
RCSB PDBPDBeBMRBAdv. SearchSearch help

7B66

Structure of NUDT15 R139H Mutant in complex with TH7755

7B66 の概要
エントリーDOI10.2210/pdb7b66/pdb
分子名称Nucleotide triphosphate diphosphatase NUDT15, (R)-6-((2-methyl-4-(1-methyl-1H-indole-5-carbonyl)piperazin-1-yl)sulfonyl)benzo[d]oxazol-2(3H)-one (3 entities in total)
機能のキーワードinhibitor, complex, nucleoside triphosphate pyrophosphohydrolase, hydrolase
由来する生物種Homo sapiens (Human)
タンパク質・核酸の鎖数4
化学式量合計76281.82
構造登録者
Rehling, D.,Stenmark, P. (登録日: 2020-12-07, 公開日: 2021-03-24, 最終更新日: 2024-01-31)
主引用文献Rehling, D.,Zhang, S.M.,Jemth, A.S.,Koolmeister, T.,Throup, A.,Wallner, O.,Scaletti, E.,Moriyama, T.,Nishii, R.,Davies, J.,Desroses, M.,Rudd, S.G.,Scobie, M.,Homan, E.,Berglund, U.W.,Yang, J.J.,Helleday, T.,Stenmark, P.
Crystal structures of NUDT15 variants enabled by a potent inhibitor reveal the structural basis for thiopurine sensitivity.
J.Biol.Chem., 296:100568-100568, 2021
Cited by
PubMed Abstract: The enzyme NUDT15 efficiently hydrolyzes the active metabolites of thiopurine drugs, which are routinely used for treating cancer and inflammatory diseases. Loss-of-function variants in NUDT15 are strongly associated with thiopurine intolerance, such as leukopenia, and preemptive NUDT15 genotyping has been clinically implemented to personalize thiopurine dosing. However, understanding the molecular consequences of these variants has been difficult, as no structural information was available for NUDT15 proteins encoded by clinically actionable pharmacogenetic variants because of their inherent instability. Recently, the small molecule NUDT15 inhibitor TH1760 has been shown to sensitize cells to thiopurines, through enhanced accumulation of 6-thio-guanine in DNA. Building upon this, we herein report the development of the potent and specific NUDT15 inhibitor, TH7755. TH7755 demonstrates a greatly improved cellular target engagement and 6-thioguanine potentiation compared with TH1760, while showing no cytotoxicity on its own. This potent inhibitor also stabilized NUDT15, enabling analysis by X-ray crystallography. We have determined high-resolution structures of the clinically relevant NUDT15 variants Arg139Cys, Arg139His, Val18Ile, and V18_V19insGlyVal. These structures provide clear insights into the structural basis for the thiopurine intolerance phenotype observed in patients carrying these pharmacogenetic variants. These findings will aid in predicting the effects of new NUDT15 sequence variations yet to be discovered in the clinic.
PubMed: 33753169
DOI: 10.1016/j.jbc.2021.100568
主引用文献が同じPDBエントリー
実験手法
X-RAY DIFFRACTION (1.6 Å)
構造検証レポート
Validation report summary of 7b66
検証レポート(詳細版)ダウンロードをダウンロード

226707

件を2024-10-30に公開中

PDB statisticsPDBj update infoContact PDBjnumon